Myocardial Inflammation in Systemic Lupus Erythematosus
NCT01761422 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-12-18
Summary
The goal is to assess for myocardial edema on cardiac MRI during SLE flare to assess for myocardial inflammation.
Conditions
Sponsors & Collaborators
-
Stacy Ardoin MD
lead OTHER
Principal Investigators
-
Stacy Ardoin, MD · Ohio State University
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-01
- Primary Completion
- 2026-11-01
- Completion
- 2026-11-01
Countries
- United States
Study Locations
More Related Trials
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Cardiac Imaging in Systemic Disorders: the ORACLES Registry
NCT07134166 ·Status: NOT_YET_RECRUITING
-
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
NCT04018222 ·Status: UNKNOWN
-
QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE)
NCT01031797 ·Status: COMPLETED
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
NCT00610805 ·Status: WITHDRAWN ·Phase: NA
-
Systemic Lupus Erythematous and Heart Conduction Disorders
NCT02162992 ·Status: COMPLETED
-
Application of MRI for Musculoskeletal Involvement in SLE
NCT04035265 ·Status: UNKNOWN ·Phase: NA
-
Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
NCT00188188 ·Status: UNKNOWN ·Phase: PHASE4
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
NCT00042523 ·Status: COMPLETED
-
Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance
NCT01180361 ·Status: COMPLETED
-
Dynamic Imaging of Variation in Lupus Nephritis
NCT03180021 ·Status: COMPLETED
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
NCT01702038 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Autoinflammatory Disease Cohort
NCT07126145 ·Status: NOT_YET_RECRUITING
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
NCT05440422 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of Lipids in Immune Cell Function in SLE Patients
NCT04361734 ·Status: UNKNOWN
-
Flow Mediated Dilation in Association With Hyperuricemia
NCT05342285 ·Status: UNKNOWN
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
NCT07340463 ·Status: RECRUITING ·Phase: PHASE2
-
At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring
NCT05451277 ·Status: UNKNOWN
-
Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 ·Status: UNKNOWN